Purpose:To compare and evaluate the differences in the therapeutic effects of different surgical methods for treating high myopia cataracts using supracapsular phacoemulsification technology and intracapsular phacoemulsification respectively, and to provide a basis for choosing the best surgical method.
Methods: A total of 240 patients (268 eyes) with high myopia and cataract who underwent cataract surgery in our hospital from December 2020 to May 2022 were enrolled,of which 120 patients (136 eyes) were selected as the supracapsular phacoemulsification group, and 120 patients (132 eyes) as the intracapsular phacoemulsification group.The intraoperative average ultrasonic energy (AVE), effective phacoemulsification time (EPT), intraoperative complications, postoperative 1d, 1mo visual acuity and the corneal endothelial cell counts were recorded and compared.
Results:Comparing the subgroups with the same nuclear hardness between the two groups, the AVE and EPT of the supracapsular group were lower than those of the intracapsular group, and the difference was significant(P<0.05). Postoperative 1 mo UCVA and BCVA between two groups were significantly higher than those of postoperative 1d, and the difference was statistically significant (P<0.05). Posterior capsular rupture occurred in 0 eyes in the supracapsular group and6 eyes in the intracapsular group.There were no other serious surgical complications.
Conclusion:The supracapsular method is simpler than the intracapsular phacoemulsification technique, uses less energy, takes less time, and has fewer complications.Therefore, Therefore, the results of this study support the use of supracapsular method for phacoemulsification cataract surgery in myopes.